2565 — Pegbio Co Balance Sheet
0.000.00%
- HK$24.41bn
- HK$24.15bn
Annual balance sheet for Pegbio Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 340 | 182 |
| Net Total Receivables | 0.05 | 3.36 |
| Prepaid Expenses | ||
| Total Current Assets | 345 | 190 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 6.95 | 5.1 |
| Net Intangible Assets | ||
| Long Term Notes Receivable | ||
| Total Assets | 368 | 218 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 165 | 158 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Minority Interest | ||
| Total Other Liabilities | ||
| Total Liabilities | 178 | 166 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 190 | 52.2 |
| Total Liabilities & Shareholders' Equity | 368 | 218 |
| Total Common Shares Outstanding |